Islet-after-kidney transplantation versus kidney alone in kidney transplant recipients with type 1 diabetes (KAIAK): a population-based target trial emulation in France.
Maanaoui M, Lenain R, Foucher Y, Buron F, Blancho G, Antoine C, Caillard S, Kessler L, Le Quintrec M, Villard O, Anglicheau D, Büchler M, Brodin-Sartorius A, Frimat L, Malvezzi P, Lablanche S, Badet L, Esposito L, Chetboun M, Hamroun A, Kerr-Conte J, Berney T, Vantyghem MC, Hazzan M, Pattou F; TREPID-ABM study group.
Maanaoui M, et al.
Lancet Diabetes Endocrinol. 2024 Oct;12(10):716-724. doi: 10.1016/S2213-8587(24)00241-9. Epub 2024 Sep 6.
Lancet Diabetes Endocrinol. 2024.
PMID: 39250921